What does CUSIP 05464T104 represent in this 13F holders report?

CUSIP 05464T104 is the security identifier for AXSM - Axsome Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held AXSM - Axsome Therapeutics, Inc. - Common Stock in Q1 2019?

64 institutional investors reported AXSM - Axsome Therapeutics, Inc. - Common Stock for Q1 2019. Use the holders table for investor-level position and value details.

Axsome Therapeutics, Inc. - Common Stock (AXSM)

CUSIP: 05464T104

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class: Equity / Common Stock
Shares outstanding: 48,932,355
Total 13F shares: 14,726,528
Share change: +10,868,724
Total reported value: $209,555,043
Put/Call ratio: 52%
Price per share: $14.23
Number of holders: 64
Value change: +$159,660,613
Number of buys: 49
Number of sells: 18

Security key

05464T104

Report period

Q1 2019

Institutions

Top holders

AXSM full security history Newer quarter: Q2 2019 Previous quarter: Q4 2018 Axsome Therapeutics, Inc. SEC filings Axsome Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 05464T104

Newer quarter: Q2 2019 Previous quarter: Q4 2018

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AXSM - Axsome Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ALETHEA CAPITAL MANAGEMENT, LLC	13F	Company	1.9%	908,429	$2,562,000	—	31 Dec 2018	13F
STIFEL FINANCIAL CORP	13F	Company	0.83%	404,145	$1,140,000	—	31 Dec 2018	13F
Sio Capital Management, LLC	13F	Company	0.78%	380,812	$1,074,000	—	31 Dec 2018	13F
VANGUARD GROUP INC	13F	Company	0.69%	338,704	$955,000	—	31 Dec 2018	13F
ROYCE & ASSOCIATES LP	13F	Company	0.68%	332,400	$937,000	—	31 Dec 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.63%	308,802	$871,000	—	31 Dec 2018	13F
Point72 Asset Management, L.P.	13F	Company	0.51%	250,000	$705,000	—	31 Dec 2018	13F
Endurant Capital Management LP	13F	Company	0.43%	209,195	$590,000	—	31 Dec 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.19%	94,205	$265,000	—	31 Dec 2018	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.17%	84,165	$237,000	—	31 Dec 2018	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.15%	73,713	$208,000	—	31 Dec 2018	13F
BlackRock Finance, Inc.	13F	Company	0.13%	64,049	$181,000	—	31 Dec 2018	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.13%	63,000	$178,000	—	31 Dec 2018	13F
Mariner, LLC	13F	Company	0.08%	41,525	$117,000	—	31 Dec 2018	13F
Spark Investment Management LLC	13F	Company	0.08%	40,900	$115,000	—	31 Dec 2018	13F
Bank of New York Mellon Corp	13F	Company	0.07%	34,690	$98,000	—	31 Dec 2018	13F
Worth Venture Partners, LLC	13F	Company	0.07%	34,448	$96,000	—	31 Dec 2018	13F
NORTHERN TRUST CORP	13F	Company	0.06%	30,453	$86,000	—	31 Dec 2018	13F
BALDWIN WEALTH PARTNERS LLC/MA	13F	Company	0.06%	29,241	$82,000	—	31 Dec 2018	13F
SHANDA ASSET MANAGEMENT HOLDINGS Ltd	13F	Company	0.04%	19,958	$56,000	—	31 Dec 2018	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.03%	15,110	$43,000	—	31 Dec 2018	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.03%	13,284	$37,000	—	31 Dec 2018	13F
BARCLAYS PLC	13F	Company	0.02%	10,500	$30,000	—	31 Dec 2018	13F
GROUP ONE TRADING LLC	13F	Company	0.02%	10,094	$28,000	—	31 Dec 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.02%	9,200	$26,000	—	31 Dec 2018	13F
Sandy Spring Bank	13F	Company	0.02%	8,755	$25,000	—	31 Dec 2018	13F
MORGAN STANLEY	13F	Company	0.01%	6,047	$17,000	—	31 Dec 2018	13F
MEEDER ASSET MANAGEMENT INC	13F	Company	0.01%	2,533	$7,000	—	31 Dec 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	2,327	$7,000	—	31 Dec 2018	13F
SeaCrest Wealth Management, LLC	13F	Company	0%	2,000	$6,000	—	31 Dec 2018	13F
LADENBURG THALMANN FINANCIAL SERVICES INC.	13F	Company	0%	1,591	$4,000	—	31 Dec 2018	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0%	1,100	$3,000	—	31 Dec 2018	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	888	$3,000	—	31 Dec 2018	13F
SIMPLEX TRADING, LLC	13F	Company	0%	400	$1,000	—	31 Dec 2018	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	3	$8	—	31 Dec 2018	13F

Institutional Holders of Axsome Therapeutics, Inc. - Common Stock (AXSM) as of Q1 2019

As of 31 Mar 2019, Axsome Therapeutics, Inc. - Common Stock (AXSM) was held by 64 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,726,528 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, ALETHEA CAPITAL MANAGEMENT, LLC, VHCP Management III, LLC, Invesco Ltd., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, RTW INVESTMENTS, LP, VHCP Management II, LLC, and BlackRock Inc.. This page lists 64 institutional shareholders reporting positions in this security for the Q1 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2019 vs Q4 2018 Across Filers

Q4 2018 holders

Q1 2019 holders

Holder diff

Investor	Q4 2018 Shares	Q1 2019 Shares	Share Diff	Share Chg %	Q4 2018 Value $	Q1 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.